MicroRNA Profiling in Papillary Thyroid Cancer
View abstract on PubMed
Summary
This summary is machine-generated.This study identified distinct microRNA (miRNA) expression profiles in papillary thyroid carcinoma (PTC) by analyzing numerous patient samples. These findings offer potential biomarkers for PTC diagnosis and prognosis.
Area Of Science
- Oncology
- Molecular Biology
- Genetics
Background
- Papillary thyroid carcinoma (PTC) pathogenesis and prognosis are linked to genetic alterations.
- MicroRNA (miRNA) expression dysregulation is implicated in thyroid carcinoma development.
Purpose Of The Study
- To identify dysregulated miRNAs associated with PTC development using a large cohort of matched tumor and control samples.
- To analyze a wider variety of miRNA types and numbers than previous studies.
Main Methods
- Analyzed expression levels of 2656 human miRNAs in 236 thyroid tissue samples (118 tumor/control pairs).
- Utilized KEGG pathway and Gene Ontology (GO) framework analyses to link miRNA dysregulation to biological processes.
- Investigated associations between miRNA expression and clinicopathological variables.
Main Results
- Identified 30 significant differentially expressed miRNAs in PTC, including upregulated miR-551b, miR-146b, miR-221, miR-222, miR-375, and downregulated miR-873, miR-204.
- Found miRNA patterns in KEGG and GO databases similar to PTC, such as those in prostate cancer and HIF-1 signaling.
- Discovered 352 potential associations between miRNA expressions and clinicopathological variables.
Conclusions
- A distinct miRNA expression profile in PTC was identified, enhancing understanding of disease pathogenesis.
- Deviations in miRNA expression and signaling pathways may serve as potential biomarkers for PTC diagnosis, prognosis, and therapeutic targets.

